Telyse 40mg Injection
By Telyse
Rx
1 Injection in a Vial

Composition
Tenecteplase(40mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
April, 2026

liver
There is limited information about using Tenectelex 40mg Injection in patients with liver disease. It is important to consult your doctor before using this medication if you have liver issues.

kidney
Limited information exists regarding the safety and effectiveness of Tenectelex 40mg Injection in individuals with kidney issues. It is advisable to seek guidance from your healthcare provider.

alcohol
It is important to consult your doctor regarding the safety of consuming alcohol while using Tenectelex 40mg Injection. The effects of alcohol with this medication are currently unknown.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Tenectelex 40mg Injection.

pregnancy
Tenectelex 40mg Injection is not recommended during pregnancy, as animal studies have shown potential harm to the developing baby. It is important to consult your doctor for a thorough evaluation of the benefits and risks before using this medication.

breastfeeding
During breastfeeding, caution is advised when using Tenectelex 40mg Injection. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | Carboxylic Acid Derivative |
Therapeutic Class | - |
Action Class | Plasminogen Activators- Thrombolytics |
₹49390
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024